SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Aegis Therapeutics, LLC Awarded Patent for Monoclonal Antibody Formulations That Avoid Oxidative Damage Due to Polysorbate Surfactants